ÂÜÀòÂÒÂ×

David Harel is the current CEO of CytoReason. Prior to this, they were the President of Virtual Officeware from January 2012 to December 2014. David has also held the position of Managing Director at Rosemore Capital and Board Member at Columbia Northwest, Inc. Harel has a wealth of experience in the healthcare industry, having co-founded Reticle Partners and served as Managing Director at Pennsylvania Growth Fund. David is committed to developing effective tools that improve patient care and secure healthcare excellence.

David Harel received their MBA from Carnegie Mellon University - Tepper School of Business with a focus in Entrepreneurship/Entrepreneurial Studies. David also attended the Summer Institute for International Students.

Elina Starosvetsky - Co-Founder & VP Biology, Adir Katz - VP R&D, and Elisha Nathan - VP of Strategic Alliances report to David Harel.